Home
>
National Drug Code (NDC)
>
Fosinopril Sodium and Hydrochlorothiazide
Fosinopril Sodium and Hydrochlorothiazide - 63304-404-30 - (Fosinopril Sodium and Hydrocholorothiazide)
Drug Information of Fosinopril Sodium and Hydrochlorothiazide
| Product NDC: | 63304-404 |
| Proprietary Name: | Fosinopril Sodium and Hydrochlorothiazide |
| Non Proprietary Name: | Fosinopril Sodium and Hydrocholorothiazide |
| Active Ingredient(s): | 20; 12.5 mg/1; mg/1 & nbsp; Fosinopril Sodium and Hydrocholorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fosinopril Sodium and Hydrochlorothiazide
| Product NDC: | 63304-404 |
| Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076739 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20041220 |
Package Information of Fosinopril Sodium and Hydrochlorothiazide
| Package NDC: | 63304-404-30 |
| Package Description: | 30 TABLET in 1 BOTTLE (63304-404-30) |
NDC Information of Fosinopril Sodium and Hydrochlorothiazide
| NDC Code | 63304-404-30 |
| Proprietary Name | Fosinopril Sodium and Hydrochlorothiazide |
| Package Description | 30 TABLET in 1 BOTTLE (63304-404-30) |
| Product NDC | 63304-404 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fosinopril Sodium and Hydrocholorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20041220 |
| Marketing Category Name | ANDA |
| Labeler Name | Ranbaxy Pharmaceuticals Inc. |
| Substance Name | FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE |
| Strength Number | 20; 12.5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
